Patents by Inventor Koji OHMOTO

Koji OHMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable depot formulation comprising optically active tolvaptan and process of producing the same
    Patent number: 9597283
    Abstract: This invention provides an injectable formulation to be administered intramuscularly or subcutaneously that is used for the prevention or treatment of polycystic kidney disease, and that can maintain a therapeutically effective blood concentration of tolvaptan for a long period of time; and a process for producing the same. More specifically, this invention relates to an injectable depot formulation comprising (1) a particle containing optically active tolvaptan as an active ingredient and (2) a pharmaceutically acceptable carrier for injection, and a process for producing the same.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: March 21, 2017
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Daiki Kaneko, Takakuni Matsuda, Kenichi Miyata, Kai Suzuki, Hiroyuki Fujiki, Shizuo Kinoshita, Koji Ohmoto, Miki Aihara
  • DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE
    Publication number: 20160250222
    Abstract: The present invention provides a combined drug for an injectable depot formulation having a superior effect of preventing and/or treating polycystic kidney disease. More specifically, the present invention relates to a drug for preventing and/or treating polycystic kidney disease, which is an injectable depot formulation comprising a particle containing tolvaptan or a prodrug thereof and a somatostatin analogue. The present invention also relates to a method for preventing and/or treating polycystic kidney disease using the drug.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 1, 2016
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hiroyuki FUJIKI, Miki AIHARA, Katsuji HATTORI, Koji OHMOTO, Takakuni MATSUDA, Daiki KANEKO
  • INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME
    Publication number: 20150352041
    Abstract: This invention provides an injectable formulation to be administered intramuscularly or subcutaneously that is used for the prevention or treatment of polycystic kidney disease, and that can maintain a therapeutically effective blood concentration of tolvaptan for a long period of time; and a process for producing the same. More specifically, this invention relates to an injectable depot formulation comprising (1) a particle containing optically active tolvaptan as an active ingredient and (2) a pharmaceutically acceptable carrier for injection, and a process for producing the same.
    Type: Application
    Filed: December 27, 2013
    Publication date: December 10, 2015
    Inventors: Daiki KANEKO, Takakuni MATSUDA, Kenichi MIYATA, Kai SUZUKI, Hiroyuki FUJIKI, Shizuo KINOSHITA, Koji OHMOTO, Miki AIHARA